Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasms, Multiple Primary × envafolimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Biliary Tract Neoplasms 3 Sarcoma 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Rectal Neoplasms 1 Rare Tumour 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neoplasms, Multiple Primary 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Meningeal Carcinomatosis 1 Lung Neoplasms 1 Histiocytoma, Malignant Fibrous 1 HER2-positive Breast Cancer 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Dermatofibrosarcoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Advanced Renal Cell Carcinoma (aRCC) 1 Advanced Refractory Solid Tumors 1 Advanced Pancreatic Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04182789 2019-12-02

CPOG035-01

RenJi Hospital

Phase 2 Unknown

Neoplasms, Multiple Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡